Artemisinin combination therapies for treatment of uncomplicated malaria in Uganda

Related Experiment Video

Updated: Aug 6, 2026

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds
07:14

Ookluc: A Plasmodium berghei Line for Identifying Transmission-blocking Compounds

Published on: July 11, 2025

Hasifa Bukirwa1, Adoke Yeka, Moses R Kamya

  • 1Uganda Malaria Surveillance Project, Kampala, Uganda.

Plos Clinical Trials
|July 28, 2006
PubMed

Insights

Artemisinin combination therapies (ACTs) like amodiaquine + artesunate and artemether-lumefantrine are effective against uncomplicated malaria in Uganda. Artemether-lumefantrine showed better prevention of new infections compared to amodiaquine + artesunate.

Area of Science:

  • Malariology
  • Tropical Medicine
  • Pharmacology

Background:

  • Uncomplicated falciparum malaria remains a significant health burden in holoendemic regions.
  • Artemisinin combination therapies (ACTs) are recommended for malaria treatment.
  • Evaluating the comparative efficacy and safety of different ACTs is crucial for optimizing treatment guidelines.

Purpose of the Study:

  • To compare the efficacy and safety of amodiaquine + artesunate versus artemether-lumefantrine for treating uncomplicated falciparum malaria in Ugandan children.
  • To assess the risk of recurrent malaria and parasitemia, distinguishing between recrudescence and new infections.

Main Methods:

  • A randomized single-blind controlled trial was conducted in Tororo, Uganda, a high malaria transmission area.
  • Participants included children aged 1-10 years with confirmed uncomplicated P. falciparum malaria.
  • Efficacy outcomes, including recurrent symptomatic malaria and parasitemia at 28 days, were assessed, with genotyping to differentiate new infections from recrudescences.

Main Results:

  • Both amodiaquine + artesunate and artemether-lumefantrine demonstrated high efficacy, with very few recrudescences observed.
  • Recurrent malaria due to new infections was common for both regimens.
  • Artemether-lumefantrine showed a significantly lower risk of recurrent symptomatic malaria (27%) and parasitemia (51%) compared to amodiaquine + artesunate (42% and 66%, respectively).
  • Both ACTs were well-tolerated with infrequent serious adverse events.

Conclusions:

  • Both amodiaquine + artesunate and artemether-lumefantrine are highly efficacious for uncomplicated malaria treatment.
  • Artemether-lumefantrine provided superior protection against new malaria infections compared to amodiaquine + artesunate in this holoendemic setting.
  • Integrating ACTs with malaria transmission prevention strategies is essential for long-term control.
  • Further research is needed on the impact of frequent re-treatment on ACT efficacy, safety, and cost-effectiveness.
Abstract

More Related Videos

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors05:28

Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors

Published on: May 12, 2022

Related Concept Videos

Anthelminthic Agents01:15

Anthelminthic Agents

Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Malaria01:29

Malaria

Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...